| Mouth dissolving tablets: A review D Kaushik, H Dureja, TR Saini INDIAN DRUGS-BOMBAY- 41 (4), 187-193, 2004 | 239 | 2004 |
| Cosmeceuticals: An emerging concept H Dureja, D Kaushik, M Gupta, V Kumar, V Lather Indian Journal of Pharmacology 37 (3), 155, 2005 | 178 | 2005 |
| Developments in nutraceuticals H Dureja, D Kaushik, V Kumar Indian journal of pharmacology 35 (6), 363-372, 2003 | 128 | 2003 |
| Simulation of Skin Permeability in Chitosan Membranes Dureja Harish, Tiwary A. K. and Gupta Sunil International Journal of Pharmaceutics 213, 193-198, 2001 | 120 | 2001 |
| Predicting anti-HIV-1 activity of 6-arylbenzonitriles: Computational approach using superaugmented eccentric connectivity topochemical indices H Dureja, S Gupta, AK Madan Journal of Molecular Graphics and Modelling 26 (6), 1020-1029, 2008 | 97 | 2008 |
| Superaugmented eccentric connectivity indices: new-generation highly discriminating topological descriptors for QSAR/QSPR modeling H Dureja, AK Madan Medicinal Chemistry Research 16 (7), 331-341, 2007 | 89 | 2007 |
| Anti‐inflammatory and anticancer activities of Naringenin‐loaded liquid crystalline nanoparticles in vitro R Wadhwa, KR Paudel, LH Chin, CM Hon, T Madheswaran, G Gupta, ... Journal of food biochemistry 45 (1), e13572, 2021 | 85 | 2021 |
| Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases M Mehta, N Sharma, M Vyas, N Khurana, PK Maurya, H Singh, ... Chemico-biological interactions 304, 10-19, 2019 | 72 | 2019 |
| Formulation and evaluation of olanzapine mouth dissolving tablets by effervescent formulation approach D Kaushik, H Dureja, TR Saini INDIAN DRUGS-BOMBAY- 41, 410-412, 2004 | 71 | 2004 |
| Topochemical models for prediction of cyclin-dependent kinase 2 inhibitory activity of indole-2-ones H Dureja, AK Madan Journal of Molecular Modeling 11 (6), 525-531, 2005 | 68 | 2005 |
| Orally disintegrating tablets: An overview of melt-in mouth tablet technologies and techniques D Kaushik, H Dureja, TR Saini Tablets capsules 2 (1), 30-6, 2004 | 63 | 2004 |
| Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations NK Jha, S Ojha, SK Jha, H Dureja, SK Singh, SD Shukla, DK Chellappan, ... Journal of Molecular Neuroscience 71 (11), 2192-2209, 2021 | 59 | 2021 |
| Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via Down Regulation of Nuclear p65 and HIF-1α A AA Aljabali, H A. Bakshi, F L. Hakkim, YA Haggag, K M. Al-Batanyeh, ... Cancers 12 (1), 113, 2020 | 54 | 2020 |
| Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update M Mehta, DS Dhanjal, KR Paudel, B Singh, G Gupta, S Rajeshkumar, ... Inflammopharmacology 28 (4), 795-817, 2020 | 52 | 2020 |
| Formulation development and evaluation of alginate microspheres of ibuprofen M Nagpal, DK Maheshwari, P Rakha, H Dureja, S Goyal, G Dhingra Journal of Young Pharmacists 4 (1), 13-16, 2012 | 47 | 2012 |
| Topological models for prediction of pharmacokinetic parameters of cephalosporins using random forest, decision tree and moving average analysis H DUREJA, S GUPTA, AK MADAN Scientia Pharmaceutica 76 (3), 377-394, 2008 | 47 | 2008 |
| Nanoparticle technology for the delivery of poorly water-soluble drugs V Kharb, M Bhatia, H Dureja, D Kaushik Pharmaceutical technology (2003) 30 (2), 2006 | 46 | 2006 |
| Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases DK Chellappan, LW Yee, KY Xuan, K Kunalan, LC Rou, LS Jean, LY Ying, ... Drug development research 81 (4), 419-436, 2020 | 41 | 2020 |
| Development and optimization of boswellic acid-loaded proniosomal gel M Mehta, H Dureja, M Garg Drug delivery 23 (8), 3072-3081, 2016 | 40 | 2016 |
| What is computational toxicology? B Reisfeld, AN Mayeno Computational Toxicology, 3-7, 2012 | 39 | 2012 |
